Mark Verratti
Patrimonio netto: 2 M $ in data 31/07/2026
Patrimonio netto: 2 M $ in data 31/07/2026
Mark Steven Verratti is currently Managing Director at Myriad Genetics GmbH and Chief Operating Officer at Myriad Genetics, Inc. Former positions include Vice President-Sales at LivaNova USA, Inc. from 2005 to 2012, and SVP, Chief Sales & Business Development Officer at Assurex Health, Inc. Education includes undergraduate studies at The Pennsylvania State University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 14/04/2026 | 629.646 ( 0,67% ) | 2 M $ | 31/07/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| MYRIAD GENETICS, INC. | Direttore operativo | 30/04/2025 |
Myriad Genetics GmbH
Myriad Genetics GmbH Pharmaceuticals: MajorHealth Technology Develops therapeutic and predictive medicine products | Amministratore Delegato | - |
| Società | Posizione | Fine |
|---|---|---|
Assurex Health, Inc.
Assurex Health, Inc. Pharmaceuticals: MajorHealth Technology Operates as a personalized medicine company | Presidente | - |
| CYBERONICS, INC. | Vendite & Marketing | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 5 |
|---|---|
LivaNova USA, Inc.
LivaNova USA, Inc. Medical SpecialtiesHealth Technology Engages in design, development, sale and marketing of implantable medical devices | Health Technology |
Myriad Genetics, Inc.
Myriad Genetics, Inc. Medical SpecialtiesHealth Technology Develops therapeutic and predictive medicine products | Health Technology |
The Pennsylvania State University
The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Assurex Health, Inc.
Assurex Health, Inc. Pharmaceuticals: MajorHealth Technology Operates as a personalized medicine company | Health Technology |
Myriad Genetics GmbH
Myriad Genetics GmbH Pharmaceuticals: MajorHealth Technology Develops therapeutic and predictive medicine products | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale